TP53 WT ALLELE

Clinical trials for TP53 WT ALLELE explained in plain language.

Never miss a new study

Get alerted when new TP53 WT ALLELE trials appear

Sign up with your email to follow new studies for TP53 WT ALLELE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Early trial aims to tame tough cancers with Two-Pronged attack

Disease control Ongoing

This early-stage study is testing a new drug, ALRN-6924, combined with a standard chemotherapy (paclitaxel) for people with advanced solid tumors that have spread or cannot be removed by surgery. The main goals are to find the safest and most effective dose of this combination an…

Matched conditions: TP53 WT ALLELE

Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 13, 2026 15:06 UTC

TP53 WT ALLELE

Get alerted when new TP53 WT ALLELE trials appear

Early trial aims to tame tough cancers with Two-Pronged attack